Product market fit validation for B2B teams
We test whether real buyers will fund the problem you solve, then build your go-to-market around whatever the answer turns out to be.
What product market fit looks like in numbers
Fit shows up as a renewal nobody had to fight for. As a buyer moving budget off something else to fund you. As an account that expands without your team building the business case for them, and as a sales cycle that shortens because the buyer arrived having already decided the problem is worth money.
Interest looks almost identical from the inside. People take the meeting, praise the demo, forward it to a colleague, sign a pilot. None of that requires anyone to give up anything they would miss, which is why a pipeline can be busy and a business can still be stuck.
Product market fit means one defined group of buyers funds this problem repeatedly, stays without rescue, and tells people in the same position. The third part is what turns fit into growth that stops costing a pound of spend for every pound of revenue.
How missing fit shows up in your numbers
The absence of fit is measurable long before anyone in the company says the words out loud. It usually surfaces in some combination of these.
Deals close on discount.
Price is the only lever that reliably moves a deal forward, which means the buyer wants it and nobody has decided they need it this year.
Pilots stall before purchase.
Trials and proofs of concept fill up easily. The conversion rate from pilot to paid becomes a number that quietly stops appearing on slides.
Every account needs bespoke work.
Customers stay because someone built them something specific. That is survivable at five customers and fatal at fifty.
Churn cancels out new revenue.
The top of the funnel looks healthy while net revenue moves sideways, because the leak is downstream of everything marketing is being measured on.
Growth tracks spend exactly.
Pipeline rises and falls with budget in near lockstep, with nothing compounding underneath it.
The pitch changes every time.
The story gets rewritten per prospect, because no single version of it has worked often enough to keep.
One of these has ordinary explanations. Four at once is the market telling you something specific about who this product is actually for.
Why early signals get misread
Most early evidence is collected in conditions built to be encouraging. Discovery calls reward politeness. Advisors want to be useful. Early adopters try new tools because trying new tools is what they do, and a free account costs them nothing they would miss. The common thread is that none of those signals come from someone facing a consequence for being wrong.
A pilot agreement commits a champion, not a budget holder. A waitlist commits curiosity. Even a first paying customer can be a favour from someone who liked the founder, which is a real thing that happens and a terrible basis for a hiring plan. A signal only carries weight when it costs the buyer something they would rather keep: budget already allocated elsewhere, their team's time, a competing priority they now have to drop. That distinction is the whole of it, and it is the pattern behind most expensive early mistakes we see in B2B revenue.
What validation measures at each stage
Product market fit validation follows one chain, and each link has to hold before the next one tells you anything useful.
- 1
What buyers say
Structured conversations with the people who own the budget line, not only the users who enjoyed the demo. The question under every one of them is whether this problem ranks high enough to be funded this year, against everything else competing for the same money.
- 2
What buyers do
Behaviour once the novelty is gone. Adoption without prompting, usage that survives the first month, deals that progress when the founder is not in the room. This is where enthusiasm and demand separate.
- 3
What buyers pay
Price is the least ambiguous signal available. What buyers commit, what they renew, and whether the economics still work at the number people actually pay rather than the one in your model. Pricing a painkiller behaves very differently from pricing something optional.
Satisfaction scores sit outside this chain entirely. They measure sentiment among people who already chose you, which answers a different question from whether a market exists.
How a PMF assessment runs
The fastest way to validate product market fit is to put a specific claim in front of people who can sign for it. The work is built to reach a conclusion and then act on it.
- 01
Frame the claim.
Who exactly this is for, which problem they are funding, and what evidence would settle it either way. Vague hypotheses absorb any feedback at all, which is how validation exercises end in false comfort.
- 02
Test it against economic buyers.
We take the claim to the market it names, in live conditions, and record what buyers do rather than how they rate us. Where the segment definition is still unclear, that gets settled first, because a test aimed at everyone proves nothing about anyone.
- 03
Reach a verdict, with its confidence level.
The evidence gets weighed and stated plainly. Partial fit is a common and useful finding: strong signal inside one segment, nothing in the two either side of it.
- 04
Build from what the evidence says.
Validation answers one question inside a longer loop, and where the answer lands decides which part of that loop gets worked on next.
A confirmed signal
Scale it deliberately
Through the gates the growth will depend on.
A weak signal
Rebuild the positioning
Around the segment the market did respond to.
Either way the work carries on past the answer, because a verdict on its own does not change a revenue number. If you would rather pressure-test your own signals first, bring them to a call.
What the work has produced
ACV increase in 7 weeks
MarTech AI · PMF SprintSeries A raised on validated market signal
Governance AI · PMF to RaisePipeline growth
B2B revenue engagementEfficiency gain, with a £500k ARR uplift
Cyber Security · Pipeline EngineNone of those numbers came from a verdict on its own. Each followed the build that came after it, which in some engagements meant scaling a signal that held and in others meant rebuilding around a different market than the one the team started with.
“The approach is forensic and data-driven, working backwards from the numbers, not guessing. It's exactly how it should be.”
Who we work with
A fit
- B2B teams with a product in market and revenue that will not compound.
- Founders deciding whether to scale or reposition ahead of a raise.
- Teams whose board has started asking for evidence where optimism used to be enough.
Not a fit
You want a validation exercise that confirms a decision already made, or a research document you can file.
Both are available elsewhere, and neither survives contact with a buyer who will not pay.